• PIDILIZUMAB chembl:CHEMBL2108680 Antineoplastic

    Alternate Names:

    CT-011
    PIDILIZUMAB
    chemidplus:1036730-42-3
    chembl:CHEMBL2108680

    Drug Info:

    Pharmaceutical Developer Teva and CureTech
    Source Reported Drug Name(s) CT-011
    Drug Class Monoclonal Antibody
    FDA Approval not approved
    Drug Indications antineoplastic agent
    Drug Class Therapeutic Antibodies
    (1 More Sources)

    Publications:

    • Version: 20-Jun-2017

    Alternate Names:
    CT-011 Development Name
    PIDILIZUMAB Generic Name

    Drug Info:
    Drug Class Therapeutic Antibodies

    Publications:

    • Version: 25-July-2013

    Alternate Names:
    CT-011 Drug Trade Name
    CT-011 Drug Development Name

    Drug Info:
    Drug Class Monoclonal Antibody
    Source Reported Drug Name(s) CT-011
    Pharmaceutical Developer Teva and CureTech

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D09MRL TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: